AZZ vs REGN · P/E 14, rev $1.58B vs P/E 14, rev $14.34B
AZZ Incorporated (AZZ) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
AZZ Incorporated (AZZ) is a specialty business services company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AZZ revenue for 2025-02-28 was $1.58B. Net income was $128.8M. Revenue was up 2.6% from 2024-02-29 to 2025-02-28. AZZ currently screens at market cap $4.56B and trailing P/E 14.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AZZ currently screens at market cap $4.56B and trailing P/E 14.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AZZ and REGN stock pages for the full models.
Not investment advice.